Volunteers flood cancer study
Nearly 1,400 cancer patients have signed up to be one of the 15 to 30 participants in the first human trial of endostatin, an experimental drug that has been shown to shrink tumors in mice. The
Nearly 1,400 cancer patients have signed up to be one of the 15 to 30 participants in the first human trial of endostatin, an experimental drug that has been shown to shrink tumors in mice. The